comparemela.com
Home
Live Updates
Iotech Mdma Ca71719l1067 - Breaking News
Pages:
Latest Breaking News On - Iotech mdma ca71719l1067 - Page 1 : comparemela.com
PharmAla Biotech and Shaman Pharma Granted First Ever Special Access Program Authorization for MDMA
This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian historyVANCOUVER, British Columbia, May 16, 2023 PharmAla Biotech Holdings. | May 16, 2023
United kingdom
British columbia
Alexandre grenier
Nick kadysh
Nicholas kadysh
Access program
Neither the canadian securities exchange
Regulation services provider
Health canada controlled drugs
Pharmala biotech holdings inc
Ccrest laboratories inc
Shaman pharma corp
Health canada special access program
Health canada
Ala biotech holdings
Shaman pharma
vimarsana © 2020. All Rights Reserved.